Bacterial bloodstream infection in critically ill patients with COVID-19: a retrospective cohort study

Mateusz Bartoszewicz1, Sławomir Lech Czaban2, Klaudia Bartoszewicz3

  • 1Department of Anaesthesiology and Intensive Care, Medical University of Bialystok, Malmeda, Bialystok, Podlaskie, 15-089, Poland.

Insights

Critically ill COVID-19 patients have a high risk of bloodstream infections (BSIs). Key risk factors include prolonged mechanical ventilation and ICU stay, with multidrug-resistant pathogens being common.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Epidemiology

Background:

  • Patients in intensive care units (ICUs) with coronavirus disease 2019 (COVID-19) face a significant risk of developing bloodstream infections (BSIs).
  • Understanding the specific characteristics and risk factors associated with BSIs in this vulnerable population is crucial for effective management.

Purpose of the Study:

  • To identify the prevalent pathogens causing BSIs in critically ill COVID-19 patients.
  • To determine the factors associated with the occurrence of BSIs in this patient group.

Main Methods:

  • A retrospective cohort study was conducted involving 201 ICU patients with COVID-19.
  • Logistic regression analysis was employed to identify risk factors for BSI, alongside an analysis of clinical characteristics and outcomes.

Main Results:

  • Bloodstream infections (BSIs) developed in 21.4% of patients, with a non-significantly higher mortality rate compared to those without BSIs.
  • Significant risk factors for BSI included duration of mechanical ventilation, ventilator-associated pneumonia, length of ICU stay, high body mass index, and male sex.
  • The primary causative pathogens were Klebsiella pneumoniae, Acinetobacter baumannii, and Enterococcus faecalis, with 87% of BSIs caused by multidrug-resistant organisms.

Conclusions:

  • Identifying common pathogens and risk factors for BSIs in COVID-19 patients is essential for timely intervention and prevention strategies.
  • Prolonged mechanical ventilation and ICU length of stay emerged as significant risk factors, highlighting the importance of infection control measures in critical care settings.
Abstract

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
242
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
338
Bacterial Signaling01:30

Bacterial Signaling

Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
32.5K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
248
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
12
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
15